Clinical Trial Update: The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluating selective estrogen receptor modulators for schizophrenia and related psychotic disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Snippet

Sponsor: The Alfred | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: COMPLETED